Eloxx Pharmaceuticals, Inc(NASDAQ:ELOX) 
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical t...
Website: http://www.eloxxpharma.com
Founded: 1999
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.00
H 0.00
L 0.00
C 0.00
V 0
10EMA
20EMA
60EMA
120EMA
250EMA